tiprankstipranks
Vaxcyte, Inc. (PCVX)
NASDAQ:PCVX
Holding PCVX?
Track your performance easily

Vaxcyte (PCVX) Financial Statements

228 Followers

Vaxcyte Financial Overview

Vaxcyte's market cap is currently ―. The company's EPS TTM is $-4.678; its P/E ratio is -18.61; Vaxcyte is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-1.12. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -103.12M$ -128.70M$ -114.35M$ -180.80M$ -92.66M
EBITDA$ -98.63M$ -114.23M$ -111.25M$ -177.85M$ -90.18M
Net Income Common Stockholders$ -103.12M$ -129.10M$ -95.02M$ -178.34M$ -92.66M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.18B$ 1.45B$ 1.49B$ 1.08B$ 1.27B
Total Assets$ 3.56B$ 2.09B$ 2.09B$ 1.41B$ 1.50B
Total Debt$ 27.96M$ 25.58M$ 27.42M$ 29.22M$ 13.81M
Net Debt$ -2.15B$ -1.43B$ -1.46B$ -1.05B$ -1.25B
Total Liabilities$ 142.11M$ 101.14M$ 107.32M$ 167.45M$ 93.34M
Stockholders Equity$ 3.42B$ 1.99B$ 1.98B$ 1.24B$ 1.40B
Cash Flow-
Free Cash Flow$ -65.66M$ -129.18M$ -164.80M$ -185.88M$ -64.89M
Operating Cash Flow$ -60.71M$ -121.39M$ -159.12M$ -128.81M$ -57.55M
Investing Cash Flow$ -917.02M$ -80.41M$ -451.07M$ -13.93M$ 22.28M
Financing Cash Flow$ 1.52B$ 110.37M$ 818.20M$ 2.73M$ 48.55M
Currency in USD

Vaxcyte Earnings and Revenue History

Vaxcyte Debt to Assets

Vaxcyte Cash Flow

Vaxcyte Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis